0001127602-20-015517.txt : 20200505
0001127602-20-015517.hdr.sgml : 20200505
20200505191208
ACCESSION NUMBER: 0001127602-20-015517
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200505
FILED AS OF DATE: 20200505
DATE AS OF CHANGE: 20200505
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thompson Tommy G
CENTRAL INDEX KEY: 0001324863
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 20850627
MAIL ADDRESS:
STREET 1: 7711 CARONDELET
CITY: ST. LOUIS
STATE: MO
ZIP: 63105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-05-05
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001324863
Thompson Tommy G
1040 SPRING ST.
SILVER SPRING
MD
20910
1
Common Stock
2020-05-05
4
S
0
3100
112.555
D
14000
I
By Family LLC
Common Stock
9050
D
This transaction was executed in multiple trades at prices ranging from $112.08 to $113.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares were transferred into a limited liability company beneficially owned by the reporting person on April 3, 2020. Shares were previously reported by the reporting person as directly owned.
/s/ John S. Hess, Jr. under Power of Attorney
2020-05-05